These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 26095439

  • 1. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R, Butterfield J.
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [Abstract] [Full Text] [Related]

  • 2. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A, Butterfield J, Weiler CR.
    J Allergy Clin Immunol Pract; 2014 Oct; 2(6):775-8. PubMed ID: 25439370
    [Abstract] [Full Text] [Related]

  • 3. Increased leukotriene E4 excretion in systemic mastocytosis.
    Butterfield JH.
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
    [Abstract] [Full Text] [Related]

  • 4. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH.
    Int Arch Allergy Immunol; 2020 Jun; 181(1):43-50. PubMed ID: 31722348
    [Abstract] [Full Text] [Related]

  • 5. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
    Taylor ML, Sehgal D, Raffeld M, Obiakor H, Akin C, Mage RG, Metcalfe DD.
    J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
    [Abstract] [Full Text] [Related]

  • 6. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J, Wenzel J, Ko Y, Bieber T, Bauer R.
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [Abstract] [Full Text] [Related]

  • 7. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
    Wiednig M, Beham-Schmid C, Kranzelbinder B, Aberer E.
    Dermatology; 2013 Mar; 227(1):67-71. PubMed ID: 24008407
    [Abstract] [Full Text] [Related]

  • 8. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH, Weiler CR.
    Int Arch Allergy Immunol; 2008 Mar; 147(4):338-43. PubMed ID: 18622141
    [Abstract] [Full Text] [Related]

  • 9. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, Castellani L, Bonetto C, Frattini F, Dama A, Martinelli G, Chilosi M, Senna G, Pizzolo G, Zanotti R.
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [Abstract] [Full Text] [Related]

  • 10. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
    Oranje AP, Mulder PG, Heide R, Tank B, Riezebos P, van Toorenenbergen AW.
    Clin Exp Dermatol; 2002 Sep; 27(6):502-6. PubMed ID: 12372095
    [Abstract] [Full Text] [Related]

  • 11. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
    Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB, Mastocytosis Centre Odense University Hospital.
    Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
    [Abstract] [Full Text] [Related]

  • 12. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
    van Toorenenbergen AW, Oranje AP.
    Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
    [Abstract] [Full Text] [Related]

  • 13. Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
    Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ, Oranje AP, van de Loosdrecht AA, van Daele PL.
    Cancer; 2006 Jul 15; 107(2):345-51. PubMed ID: 16779792
    [Abstract] [Full Text] [Related]

  • 14. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.
    Vos BJ, van der Veer E, van Voorst Vader PC, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, de Monchy JG, van Doormaal JJ, Oude Elberink JN.
    J Allergy Clin Immunol; 2015 Mar 15; 135(3):792-8. PubMed ID: 25129675
    [Abstract] [Full Text] [Related]

  • 15. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR, Jordan JH, Fiegl M, Escribano L, Bellas C, Dirnhofer S, Semper H, Simonitsch-Klupp I, Horny HP, Valent P.
    Int Arch Allergy Immunol; 2002 Jun 15; 128(2):136-41. PubMed ID: 12065914
    [Abstract] [Full Text] [Related]

  • 16. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, Kerler R, Petat-Dutter K, Horny HP, Sotlar K.
    Mod Pathol; 2014 Jan 15; 27(1):19-29. PubMed ID: 23807778
    [Abstract] [Full Text] [Related]

  • 17. Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.
    Reichard KK, Chen D, Pardanani A, McClure RF, Howard MT, Kurtin PJ, Wood AJ, Ketterling RP, King RL, He R, Morice WG, Hanson CA.
    Am J Clin Pathol; 2015 Sep 15; 144(3):493-502. PubMed ID: 26276780
    [Abstract] [Full Text] [Related]

  • 18. Mastocytosis: state of the art.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2007 Sep 15; 74(2):121-32. PubMed ID: 17587883
    [Abstract] [Full Text] [Related]

  • 19. Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.
    Kristensen T, Vestergaard H, Bindslev-Jensen C, Møller MB, Broesby-Olsen S, Mastocytosis Centre, Odense University Hospital (MastOUH).
    Am J Hematol; 2014 May 15; 89(5):493-8. PubMed ID: 24443360
    [Abstract] [Full Text] [Related]

  • 20. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
    van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.
    Allergy; 2012 May 15; 67(5):683-90. PubMed ID: 22435702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.